Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections

Charalambos Vlachopoulos1, Foteini Kosmopoulou, Demosthenes Panagiotakos

  • 11st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece. cvlachop@otenet.gr

Insights

Combining cigarette smoking and caffeine intake synergistically worsens aortic stiffness and wave reflections. This combined effect is unfavorable for cardiovascular health, impacting both acute and chronic arterial function.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Smoking and caffeine independently increase arterial stiffness.
  • Aortic stiffness and wave reflections are key indicators of cardiovascular system performance and risk.
  • Previous research established the separate effects of smoking and caffeine on arterial stiffness.

Purpose of the Study:

  • To investigate the combined acute and chronic effects of cigarette smoking and caffeine intake on aortic stiffness and wave reflections.
  • To determine if there is a synergistic interaction between smoking and caffeine on cardiovascular parameters.

Main Methods:

  • Acute effects studied in 24 healthy subjects using a randomized, placebo-controlled crossover design.
  • Chronic effects assessed in a population study of 160 healthy subjects.
  • Measured pulse-wave velocity and augmentation index to assess aortic stiffness and wave reflections.

Main Results:

  • A significant interaction between caffeine and smoking was observed for pulse-wave velocity and augmentation index in both acute and chronic studies.
  • Combined smoking and caffeine intake led to greater increases in pulse-wave velocity and augmentation index than the sum of their individual effects.
  • These synergistic effects were significant on both an acute and chronic basis.

Conclusions:

  • Cigarette smoking and caffeine intake interact synergistically to adversely affect aortic stiffness and wave reflections.
  • This interaction poses an unfavorable impact on cardiovascular health, evident in both short-term and long-term exposure.
  • The findings highlight the compounded risk associated with combined smoking and caffeine consumption.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...